Xpertens ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Bankruptcy risk for industry  7.8% 7.8% 7.8% 7.8% 7.8%  
Bankruptcy risk  12.9% 13.5% 14.0% 28.0% 15.5%  
Credit score (0-100)  18 15 15 1 13  
Credit rating  BB BB BB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Gross profit  1,220 2,087 2,323 2,154 2,142  
EBITDA  -46.9 85.7 -52.4 -303 206  
EBIT  -75.1 31.0 -112 -360 138  
Pre-tax profit (PTP)  -75.3 25.6 -114.2 -356.4 145.7  
Net earnings  -58.7 14.2 -86.3 -359.1 190.3  
Pre-tax profit without non-rec. items  -75.3 25.6 -114 -356 146  

 
See the entire income statement

Balance sheet (kDKK) 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Tangible assets total  161 221 161 104 91.3  
Shareholders equity total  -49.7 -35.5 -122 -481 -291  
Interest-bearing liabilities  0.0 2.1 84.1 17.1 70.9  
Balance sheet total (assets)  618 559 636 285 438  

Net Debt  -294 -220 9.8 -14.5 -9.4  
 
See the entire balance sheet

Volume 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  1,220 2,087 2,323 2,154 2,142  
Gross profit growth  32.3% 71.0% 11.3% -7.3% -0.6%  
Employees  0 6 6 6 5  
Employee growth %  0.0% 0.0% 0.0% 0.0% -16.7%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  618 559 636 285 438  
Balance sheet change%  185.1% -9.5% 13.7% -55.2% 53.8%  
Added value  -46.9 85.7 -52.4 -300.3 206.3  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  55 6 -120 -114 -82  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  -2.0 1.0 -1.0 -2.0 1.0  

Profitability 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  -6.2% 1.5% -4.8% -16.7% 6.4%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  -17.0% 4.9% -15.3% -45.5% 20.1%  
ROI %  -1,670.7% 2,914.4% -240.4% -684.8% 340.7%  
ROE %  -18.7% 2.4% -14.4% -77.9% 52.6%  

Solidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Equity ratio %  -7.4% -6.0% -16.1% -62.8% -39.9%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  627.1% -257.2% -18.7% 4.8% -4.6%  
Gearing %  0.0% -6.0% -69.1% -3.6% -24.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 521.2% 24.4% 19.3% 9.5%  

Liquidity 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Quick Ratio  0.7 0.5 0.6 0.2 0.5  
Current Ratio  0.7 0.5 0.6 0.2 0.5  
Cash and cash equivalent  294.2 222.4 74.3 31.6 80.3  

Capital use efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -231.8 -278.8 -309.7 -600.5 -397.5  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
2024
2024/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 14 -9 -50 41  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 14 -9 -51 41  
EBIT / employee  0 5 -19 -60 28  
Net earnings / employee  0 2 -14 -60 38